Gene Therapy for Achromatopsia (CNGB3)
NCT03001310
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Achromatopsia
Interventions
BIOLOGICAL:
AAV - CNGB3
Sponsor
MeiraGTx UK II Ltd
Collaborators
[object Object]